semaglutide alzheimer's clinical trial Obesity drug fails to slow AD/PD 2026: Novo Nordisk's semaglutide

The FDA's MedWatch database at fda.gov/safety/medwatch is the correct channel to report adverse events from compounded products

Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of drugs

And if youre losing fluid through vomiting or diarrhea side effects, dehydration can happen and, in some cases, can even become severe enough to cause kidney problems

Some patients taking semaglutide have experienced macular complications such as macular edema, which can cause blurry vision

Liposuction or bariatric surgery provides immediate results but needs longer recovery

Consulting with healthcare professionals is essential for determining the safest and most effective option